(A) Flow cytometric quantification of cell viability under chronic HS for 7 days (HS = 39 °C for HEK and HCT116 cells; HS = 40 °C for A549 and RPE1 cells) (n = 4 biologically independent samples). (B…
Values related to all graphs.
(A) Flow cytometric quantification of cell viability after 4 days of treatment with 10 μM sodium arsenite (Ars), 1% hypoxia (Hypo), 5 µM L-azetidine-2-carboxylic acid (AZC), or 250 nM tunicamycin …
Values related to all graphs of Figure 1—figure supplement 1.
(A) Gating and strategy for cell size analyses relevant to Figures 1B, E, H—3E–F, 5B, 6E, 8B and C and F, and Figure 1—figure supplement 1C, Figure 2—figure supplement 1B, Figure 3—figure supplement …
(A) Immunoblots of Hsp90α and Hsp90β in WT HEK and A549 cells, and their respective Hsp90α/β KO cells. GAPDH serves as the loading control (α KO; Hsp90α KO and β KO; Hsp90β KO) (representative …
Raw and annotated immunoblots.
Values related to all graphs.
(A) Flow cytometric quantification of cell death of A549 WT and Hsp90α/β KO cells after 4 days in 1% hypoxia (Hypo) and 10 μM sodium arsenite (Ars) treatment (n=3 biologically independent samples). …
Values related to all graphs of Figure 2—figure supplement 1.
(A) Fold change of Hsf1 activity of HEK WT, A549 WT, and their respective Hsp90α/β KO cells at 37 °C as measured by luciferase reporter assay (n=3 biologically independent samples and 2 experimental …
Values related to all graphs.
Raw and annotated immunoblots.
(A) Volcano plots of the normalized fold changes in protein levels of some of the core Hsf1 target genes (list obtained from https://hsf1base.org/) in Hsp90α/β KO cells compared to WT HEK as …
Values related to all graphs of Figure 3—figure supplement 1.
Raw and annotated immunoblots of Figure 3—figure supplement 1.
(A) Volcano plots of the normalized fold changes of molecular chaperones and co-chaperones after 1 and 4 days (first and second rows, respectively) of chronic HS determined by quantitative …
Raw and annotated immunoblots.
Values related to all graphs.
(A) Heat maps of the normalized fold changes (log2) of molecular chaperones and co-chaperones of HEK cells subjected to 1 and 4 days of chronic HS as determined by quantitative label-free proteomics …
Raw and annotated immunoblots of Figure 4—figure supplement 1.
Heat maps of the normalized fold changes (log2) of Hsp90 interactors of HEK cells subjected to 1 and 4 days of chronic HS as determined by quantitative label-free proteomics (n=3 biologically …
(A) FRAP experiments with control and heat-adapted live cells expressing EGFP. The respective box plots show the t-half values of recovery of EGFP fluorescence and the apparent EGFP diffusion …
Values related to all graphs.
(A) Scheme of the FRAP experiments. (B to D) FRAP experiments with live cells expressing EGFP. The respective box plots represent the t-half values of recovery of EGFP fluorescence and the apparent …
Values related to all graphs of Figure 5—figure supplement 1.
(A) Flow cytometric analysis of total translation of HEK WT and Hsp90α/β KO cells at 37 °C and after 4 days of chronic HS (see scheme of the experiment on the top). Nascent polypeptide chains were …
Values related to all graphs.
Raw and annotated immunoblots.
(A) Flow cytometric analysis of global translation of HEK WT and Hsp90α/β KO cells at 37 °C and after 1 day under chronic HS. See scheme of the experiment on the top. Nascent polypeptide chains were …
Values related to all graphs of Figure 6—figure supplement 1.
Raw and annotated immunoblots of Figure 6—figure supplement 1.
Representative immunoblots of some translation-related proteins in A549 cells. β-actin serves as the loading control. The bar graphs show the quantitation of three biologically independent …
Raw and annotated immunoblots of Figure 6—figure supplement 2.
Values related to all graphs of Figure 6—figure supplement 2.
Relevant to Figure 6A and E and Figure 6—figure supplement 1A and B.
(A) Flow cytometric determination of the in vivo UPS activity in chronic HS compared to 37 °C, using the Ub-M-GFP and Ub-R-GFP reporter proteins (n=4 biologically independent samples). (B) Flow …
Values related to all graphs.
(A) Flow cytometric determination of the in vivo UPS activity using the Ub-M-GFP and Ub-R-GFP reporter plasmids (n=4 biologically independent samples). (B) Flow cytometric measurement of autophagic …
Values related to all graphs of Figure 7—figure supplement 1.
(A) Gating strategy for autophagic flux measurements, relevant to Figure 7B and Figure 7—figure supplement 1B. (B) Gating strategy for measuring UPS activity; related to Figure 7A and Figure …
(A) Scheme of cell size enlargement or reduction experiments. CHX, cycloheximide; CDKi, CDK4/6 inhibitor. (B) Cell size was first enlarged by treating cells with 100 nM CDKi for 3 days; then, cells …
Values related to all graphs.
(A) Cell size was enlarged by treating cells with 100 nM CDKi for 3 days. Fold change of cell size (represented by the FSC-MFI values) and total proteins (determined as MFI-FL1 values) were analyzed …
Values related to all graphs of Figure 8—figure supplement 1.
Immunoblots in the lower panels show the endogenous Hsp90α and Hsp90β, and the exogenously overexpressed larger fusion proteins of Hsp90α (as mCherry-Hsp90α) and Hsp90β (as EGFP-Hsp90β). Images of …
Raw and annotated immunoblots.
Values related to all graphs.
(A) Flow cytometric quantification of cell size of RPE1 cells exposed to prolonged mild HS (n = 4 biologically independent samples). (B) Histograms representing the cell cycle distribution of RPE1 …
Values related to all graphs.
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Cell line (Homo-sapiens) | HEK293, Human embryonic kidney cells | ATCC | CRL-3216 | corresponding Hsp90α/β KO cell lines were generated |
Cell line (Homo-sapiens) | A549, human lung epithelial carcinoma cells | ATCC | CCL-185 | corresponding Hsp90α/β KO cell lines were generated |
Cell line (Homo-sapiens) | RPE1, human retinal epithelial cells | ATCC | CRL-4000 | |
Cell line (Homo-sapiens) | HCT116, human colon carcinoma Cells | ATCC | CCL-247 | |
Cell line (Mus musculus) | Mouse adult fibroblasts (MAFs) | Bhattacharya et al., 2022 | ||
Recombinant DNA reagent | pcDNA-Flag HSF1 wt (plasmid) | a gift from Len Neckers (Kijima et al., 2018) | transient overexpression of WT Hsf1 | |
Recombinant DNA reagent | pcDNA-Flag HSF1 C205 (plasmid) | a gift from Len Neckers (Kijima et al., 2018) | This express the Hsf1 mutant comprising only the N-terminal 205 amino acids | |
Recombinant DNA reagent | pcDNA3.1(+) (plasmid) | Thermo Fisher Scientific | #V79020 | |
Recombinant DNA reagent | pCherry.90α (plasmid) | Picard et al., 2006 | transient overexpression of Hsp90α | |
Recombinant DNA reagent | pEGFP.90β (plasmid) | Picard et al., 2006 | transient overexpression of Hsp90β | |
Recombinant DNA reagent | pmCherry-C1 (plasmid) | Picard et al., 2006 | Control for pCherry.90α | |
Recombinant DNA reagent | pEGFP-C1 (plasmid) | Clontech | #6084–1 | |
Recombinant DNA reagent | FUW mCherry-GFP-LC3 (plasmid) | a gift from Anne Brunet (Leeman et al., 2018) | Addgene #110060 | autophagy reporter plasmid |
Recombinant DNA reagent | Ub-M-GFP (plasmid) and Ub-R-GFP (plasmid) | a gift from Nico Dantuma (Dantuma et al., 2000) | Addgene #11938 and #11939 | |
Recombinant DNA reagent | HSE (WT)-Luc (plasmid) | a gift from Ueli Schibler (Reinke et al., 2008) | Hsf1 reporter plasmid | |
Recombinant DNA reagent | pEGFP-Q74 (plasmid) | a gift from David Rubinsztein (Narain et al., 1999) | Addgene # 40261 | |
Recombinant DNA reagent | pRL-CMV (plasmid) | Promega | #E2261 | |
Recombinant DNA reagent | pSpCas9(BB)–2A-Puro (PX459) (plasmid) | a gift from Feng Zhang (Ran et al., 2013) | Addgene #48139 | |
Recombinant DNA reagent | pGL3-CMV.Luc (plasmid) | a gift from Laurent Guillemot (University of Geneva) | ||
Sequence-based reagent | shHSF1-1 | This paper, from Microsynth | HSF1 shRNA 3UTR forward | 5'-CCG GGC AGG TTG TTC ATA GTC AGA ACT CGA GTT CTG ACT ATG AAC AAC CTG CTT TTT G-3' |
Sequence-based reagent | shHSF1-1 | This paper, from Microsynth | HSF1 shRNA 3UTR reverse | 5'-AAT TCA AAA AGC AGG TTG TTC ATA GTC AGA ACT CGA GTT CTG ACT ATG AAC AAC CTG C-3' |
Sequence-based reagent | shHSF1-2 | This paper, from Microsynth | HSF1 shRNA CDS forward | 5'-CCG GCC AGC AAC AGA AAG TCG TCA ACT CGA GTT GAC GAC TTT CTG TTG CTG GTT TTT G-3' |
Sequence-based reagent | shHSF1-2 | This paper, from Microsynth | HSF1 shRNA CDS reverse | 5'-AAT TCA AAA ACC AGC AAC AGA AAG TCG TCA ACT CGA GTT GAC GAC TTT CTG TTG CTG G-3' |
Chemical compound | L-azetidine-2-carboxylic acid (AZC) | Sigma-Aldrich | #P8783 | |
Chemical compound | Tunicamycin | Cell Signalling | #12819 | |
Chemical compound | Propidium iodide (PI) | Cayman Chemical | #14289–10 | |
Chemical compound | Annexin V | Biolegend | #640906 | |
Chemical compound | Phalloidin-Alexa488 | Thermo Fisher Scientific | #A12379 | |
Chemical compound | Diamidino-2-phenylindole dye (DAPI) | Thermo Fisher Scientific | #62248 | 1:30,000 in PBS, from 1 mg/ml stock solution |
Chemical compound, drug | Abemaciclib | MedChemExpress | #HY-16297A-5MG | |
Chemical compound, drug | Rapamycin | Sigma-Aldrich | #553210 | |
Commercial assay, kit | Dual-Luciferase detection kit | Promega | #E1910 | |
Commercial assay, kit | Alexa Fluor 488 NHS Ester (succinimidyl ester) | Thermo Fisher Scientific | #A20100 | |
Commercial assay, kit | Click-iT Plus OPP Alexa Fluor 594 | Thermo Fisher Scientific | #C10457 | |
Commercial assay, kit | N-succinyl-Leu-Leu-Val-Tyr-7-amino-4-methyl-coumarin (suc-LLVY-AMC) | Enzo Life Sciences | #BML-P802-0005 | |
Commercial assay, kit | CellEvent Senescence Green Flow Cytometry Assay Kit | Invitrogen | #C10840 | |
Antibody | Anti-GAPDH (Mouse monoclonal) | HyTest Ltd. | 5G4 | 1:1000 |
Antibody | Anti-Hsp25/27 (Mouse monoclonal) | StressMarq | SMC-114 | 1:1000 |
Antibody | Anti-puromycin (Mouse monoclonal) | Sigma-Aldrich | MABE343 | 1:22000 |
Antibody | Anti-Lamin B1 (Rabbit polyclonal) | Cell Signaling Technology | 12586 | 1:1000 |
Antibody | Anti-Hsp40/Hdj1 (Rabbit polyclonal) | Enzo Lifesciences | ADI-SPA-400 | 1:1000 |
Antibody | Anti-Hsf1 (Rabbit polyclonal) | Enzo Lifesciences | ADI-SPA-901 | 1:1000 |
Antibody | Anti-Hsp70 (Mouse monoclonal) | StressMarq | SMC-100 | 1:1000 |
Antibody | Anti-Phospho-eIF2α (Ser51) (Rabbit polyclonal) | Cell Signaling Technology | 3597 | 1:1000 |
Antibody | Anti-eIF2α (Rabbit polyclonal) | Cell Signaling Technology | 9722 | 1:1000 |
Antibody | Anti-Hsp90α (9D2) (Rat monoclonal) | Enzo Lifesciences | ADI-SPA-840 | 1:1000 |
Antibody | Anti-Hsp90β (scFv H90-10) (Mouse monoclonal) | Geneva Antibody Facility | ABCD_A0870 | 1:2000 |
Antibody | Anti-mTOR (Rabbit polyclonal) | Cell Signaling Technology | 2983 | 1:2000 |
Antibody | Anti-Phospho-mTOR (Ser2448) (Rabbit polyclonal) | Cell Signaling Technology | 2971 | 1:1000 |
Antibody | Anti-Phospho-S6 Ribosomal Protein (Ser235/236) (Rabbit polyclonal) | Cell Signaling Technology | 4858 | 1:1000 |
Antibody | Anti-S6 Ribosomal Protein (Rabbit polyclonal) | GeneTex | GTX130450 | 1:1000 |
Antibody | Anti-Hsc70 (Mouse monoclonal) | StressMarq | SMC-151 | 1:2000 |